Table 3.
Pre UFH injection | Post UFH injection | ||||
---|---|---|---|---|---|
FPG (mg/dL) | IRI (μU/mL) | FFA (μEq/L) | IRI (μU/mL) | FFA (μEq/L) | |
Group A | 93.3 ± 15.2 | 3.69 ± 2.93 | 650.5 ± 310.9 | 4.47 ± 2.38 | 2026.2 ± 712.1* |
Group B | 84.3 ± 11.1 | 3.16 ± 3.41 | 1159.1 ± 393.0 | 2.88 ± 3.67 | 2115.5 ± 531.3* |
P value | .0010 | .099 | <.0001 | <.0001 | .52 |
Group A: patients with minimum 6 h fasting. Group B: patients with minimum 18 h fasting and LCD preparation
UFH, unfractionated heparin; FPG, fasting plasma glucose; IRI, immunoreactive insulin; FFA, free fatty acid; LCD, low-carbohydrate diet
*P < .0001 vs before UFH administration